Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-26 @ 3:14 PM
NCT ID: NCT07365761
Eligibility Criteria: Stage 1 (For patients and nurse) \*\*\*Patients\*\*\* Inclusion Criteria: * Aged 18 years or older. * Diagnosed with gynecologic cancer and undergoing surgery. * Willing to receive E-MOTE robot and wear a smart wearable device. * Willing to complete pre-test and post-test questionnaires. Exclusion Criteria: * Unable to communicate clearly. * Unwilling or unable to participate in the study in its entirety. \*\*\*Nurse\*\*\* Inclusion Criteria: * Aged 18 years or older. * As a clinical nurse and has cared for patients who received the E-MOTE robot Exclusion Criteria: \- Unwilling to participate in the qualitative interview. Stage 2 (only for patients) \*\*\*Intervention group\*\*\* Inclusion Criteria: * Aged 18 years or older. * Diagnosed with gynecologic cancer and scheduled to undergo surgery. * Willing to receiveE-MOTE robot and to wear a smart wearable device. * Willing to complete pre-test and post-test questionnaires. Exclusion Criteria: * Unable to communicate clearly. * Unwilling or unable to participate in the study in its entirety. \*\*\*Control group\*\*\* Inclusion Criteria: * Aged 18 years or older. * Diagnosed with gynecologic cancer and scheduled to undergo surgery. * Willing to complete pre-test and post-test questionnaires. Exclusion Criteria: * Unable to communicate clearly. * Unwilling or unable to participate in the study in its entirety.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT07365761
Study Brief:
Protocol Section: NCT07365761